E2V.L Share News (E2V)

Instrumentation and controls supplier Spectris continues to rise after Friday's upgrade of full year guidance. Revenues for the four months ended October 2010 increased by 21% from a year earlier. On a like-for-like basis revenues were 16% higher than the comparable period last year. Assuming current trading levels continue the board thinks that adjusted pre-tax profits for the full year will be a bit above the top end of the range of market forecasts which, at the time of the announcement, was £115.2m.Non-executive director Russell King has bought 3,000 shares at 1182p a share. That is his first purchase of shares since his appointment in October. There was a slide in the share price of e2v Technologies following its interim figures, but the electronic component maker is still more than 80% higher after its refinancing a year ago. Revenues grew 10% to £105.4m, although that includes overdue and last time to buy orders of £10.2m. Operating profit margin quadrupled to 16%. Underlying earnings per share more than doubled to 4.57p a share in the six months to September 2010. The order book has risen to £167m. FTSE TechMARK - RisersRenovo Group (RNVO) 38.00p +4.11%Spectris (SXS) 1,224.00p +3.73%RM (RM.) 145.75p +2.64%Phoenix IT Group (PNX) 249.75p +2.57%Corin Group (CRG) 50.50p +2.02%ProStrakan Group (PSK) 94.00p +1.62%Anite (AIE) 55.75p +1.36%BATM Advanced Communications Ltd. (BVC) 22.75p +1.11%Psion (PON) 95.00p +1.06%KCOM Group (KCOM) 49.50p +1.02%FTSE TechMARK - FallersPuricore (PURI) 52.50p -5.41%Imagination Technologies Group (IMG) 344.30p -4.97%Skyepharma (SKP) 32.00p -4.48%E2V Technologies (E2V) 87.50p -4.37%Oxford Biomedica (OXB) 9.31p -4.12%Antisoma (ASM) 6.00p -4.00%NXT (NTX) 4.00p -3.15%BTG (BGC) 252.10p -2.29%Rolls-Royce Group (RR.) 598.00p -2.13%Consort Medical (CSRT) 464.00p -2.11%